Additional variable selection within each selected groups identified individual markers driving the link between the group and the outcome: sCD40L and IL4 for CLL; and MDC, eotaxin, MCP‐1, and IP10 for DLBCL. This evidence concerns the gene CCL2 and B-cell chronic lymphocytic leukemia.